v3.26.1
Pay vs Performance Disclosure
 12 Months Ended
Dec. 31, 2025
USD ($)
$ / shares
Dec. 31, 2024
USD ($)
$ / shares
Dec. 31, 2023
USD ($)
$ / shares
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
$ / shares
Pay vs Performance Disclosure          
Pay vs Performance Disclosure, Table
Pay vs. Performance Table
As required by SEC regulations, we are providing the following information about “Compensation Actually Paid,” as defined by the SEC and in Note 2 below, and certain financial performance of the Company.
Average
 Summary
Compensation
 Table Total
 for Other
 NEOs(1)
Average
Compensation
 Actually Paid
 to Other
 NEOs(2)
Value of Initial Fixed $100
Investment Based On:		GAAP
Net
Income
(Loss)
(in 000s)
Year
Summary
Compensation
Table Total for
CEO(1)
Compensation
Actually Paid
to CEO(2)
Total
Shareholder
Return
(TSR)
FTSE Nareit
Equity
Health Care
Index TSR(3)
Normalized
FFO/
Share(4)
2025$17,501,073 $40,514,474 $5,295,582 $10,454,331 $187.19 $164.51 $251,381 $3.48 
202414,438,118 21,873,324 4,327,326 5,870,995 138.59 128.07 81,153 3.19 
2023
13,520,625 10,139,836 4,107,540 3,806,036 113.40 103.13 (40,973)2.99 
2022
14,059,092 17,813,641 4,224,753 4,826,766 98.54 90.52 (47,447)2.99 
2021
14,263,728 9,914,452 6,012,810 5,967,437 107.75 116.32 49,008 2.90 
        
Company Selected Measure Name Normalized FFO/Share        
Named Executive Officers, Footnote The Named Executive Officers in the fiscal years identified above were:
YearCEOOther NEOs
2025Debra A. CafaroRobert F. Probst, Peter J. Bulgarelli, J. Justin Hutchens and Carey S. Roberts
2024Debra A. CafaroRobert F. Probst, Peter J. Bulgarelli, J. Justin Hutchens and Carey S. Roberts
2023Debra A. CafaroRobert F. Probst, Peter J. Bulgarelli, J. Justin Hutchens and Carey S. Roberts
2022Debra A. CafaroRobert F. Probst, Peter J. Bulgarelli, John D. Cobb and J. Justin Hutchens
2021Debra A. CafaroRobert F. Probst, Peter J. Bulgarelli, John D. Cobb and J. Justin Hutchens
        
Peer Group Issuers, Footnote Total Shareholder Return and FTSE Nareit Equity Health Care Index Total Shareholder Return reflect the return a stockholder would have recognized at the end of each of the fiscal years shown had they invested $100 in the Company or the FTSE Nareit Equity Health Care Index, respectively, on January 1, 2021. We have chosen to include the FTSE Nareit Equity Health Care Index TSR as our peer group TSR in this table as this is one of the primary measures of performance used in our long-term equity incentive plan.        
PEO Total Compensation Amount $ 17,501,073 $ 14,438,118 $ 13,520,625 $ 14,059,092 $ 14,263,728
PEO Actually Paid Compensation Amount $ 40,514,474 21,873,324 10,139,836 17,813,641 9,914,452
Adjustment To PEO Compensation, Footnote Compensation Actually Paid” is defined by the SEC as the total compensation reported in the Summary Compensation Table for the applicable fiscal year adjusted as follows:
2025
AdjustmentsCEOAverage Other NEOs
Deduction for Amounts Reported under the “Stock Awards” and “Option Awards” Columns in the Summary Compensation Table for Applicable FY$(12,015,051)$(3,174,175)
Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End21,882,3725,575,753
Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Vested during Applicable FY, determined as of Vesting Date——
Increase/deduction for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End12,982,1562,774,037
Increase/deduction for Awards Granted during Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior FY End to Vesting Date1,711,613325,122
Deduction of ASC 718 Fair Value of Awards Granted during Prior FY that were Forfeited during Applicable FY, determined as of Prior FY End(1,594,105)(358,076)
Increase based on Dividends or Other Earnings Paid during Applicable FY prior to Vesting Date46,41616,088
Increase based on Incremental Fair Value of Options/SARs Modified during Applicable FY——
Deduction for Change in the Actuarial Present Values reported under the “Change in Pension Value and Nonqualified Deferred Compensation Earnings” Column of the Summary Compensation Table for Applicable——
Increase for Service Cost and, if applicable, Prior Service Cost for Pension Plans——
TOTAL ADJUSTMENTS$23,013,401$5,158,749
        
Non-PEO NEO Average Total Compensation Amount $ 5,295,582 4,327,326 4,107,540 4,224,753 6,012,810
Non-PEO NEO Average Compensation Actually Paid Amount $ 10,454,331 5,870,995 3,806,036 4,826,766 5,967,437
Adjustment to Non-PEO NEO Compensation Footnote Compensation Actually Paid” is defined by the SEC as the total compensation reported in the Summary Compensation Table for the applicable fiscal year adjusted as follows:
2025
AdjustmentsCEOAverage Other NEOs
Deduction for Amounts Reported under the “Stock Awards” and “Option Awards” Columns in the Summary Compensation Table for Applicable FY$(12,015,051)$(3,174,175)
Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Remain Unvested as of Applicable FY End, determined as of Applicable FY End21,882,3725,575,753
Increase based on ASC 718 Fair Value of Awards Granted during Applicable FY that Vested during Applicable FY, determined as of Vesting Date——
Increase/deduction for Awards Granted during Prior FY that were Outstanding and Unvested as of Applicable FY End, determined based on change in ASC 718 Fair Value from Prior FY End to Applicable FY End12,982,1562,774,037
Increase/deduction for Awards Granted during Prior FY that Vested During Applicable FY, determined based on change in ASC 718 Fair Value from Prior FY End to Vesting Date1,711,613325,122
Deduction of ASC 718 Fair Value of Awards Granted during Prior FY that were Forfeited during Applicable FY, determined as of Prior FY End(1,594,105)(358,076)
Increase based on Dividends or Other Earnings Paid during Applicable FY prior to Vesting Date46,41616,088
Increase based on Incremental Fair Value of Options/SARs Modified during Applicable FY——
Deduction for Change in the Actuarial Present Values reported under the “Change in Pension Value and Nonqualified Deferred Compensation Earnings” Column of the Summary Compensation Table for Applicable——
Increase for Service Cost and, if applicable, Prior Service Cost for Pension Plans——
TOTAL ADJUSTMENTS$23,013,401$5,158,749
        
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid Versus Cumulative TSR
2636
Legend 1.jpg 
CEO Compensation Actually Paid ($)
Legend 2.jpg 
Other NEO Average Compensation Actually Paid ($)
gfx_line-cyan.jpg 
Ventas Total Shareholder Return ($)

gfx_line-teal.jpg 
FTSE NAREIT Equity Health Care Index TSR ($)
        
Compensation Actually Paid vs. Net Income
Compensation Actually Paid Versus Net Income (Loss) (in $000s)
2703
Legend 1.jpg 
CEO Compensation Actually Paid ($)
Legend 2.jpg 
Other NEO Average Compensation Actually Paid ($)
gfx_line-cyan.jpg 
Net Income (in $000s)
        
Compensation Actually Paid vs. Company Selected Measure
Compensation Actually Paid Versus Normalized FFO/Share ($)

2788
Legend 1.jpg 
CEO Compensation Actually Paid ($)
Legend 2.jpg 
Other NEO Average Compensation Actually Paid ($)
gfx_line-cyan.jpg 
Normalized FFO/Share ($)
        
Total Shareholder Return Vs Peer Group
Compensation Actually Paid Versus Cumulative TSR
2636
Legend 1.jpg 
CEO Compensation Actually Paid ($)
Legend 2.jpg 
Other NEO Average Compensation Actually Paid ($)
gfx_line-cyan.jpg 
Ventas Total Shareholder Return ($)

gfx_line-teal.jpg 
FTSE NAREIT Equity Health Care Index TSR ($)
        
Tabular List, Table
Financial Performance Measures Linked to the Compensation of Named Executive Officers
Normalized FFO/ Share
Fixed Charge Coverage
TSR Relative to the FTSE Nareit Equity Health Care Index
TSR Relative to the MSCI U.S. REIT Index
Net Debt to Further Adjusted EBITDA
        
Total Shareholder Return Amount $ 187.19 138.59 113.40 98.54 107.75
Peer Group Total Shareholder Return Amount 164.51 128.07 103.13 90.52 116.32
Net Income (Loss) $ 251,381,000 $ 81,153,000 $ (40,973,000) $ (47,447,000) $ 49,008,000
Company Selected Measure Amount | $ / shares 3.48 3.19 2.99 2.99 2.90
PEO Name Debra A. Cafaro Debra A. Cafaro Debra A. Cafaro Debra A. Cafaro Debra A. Cafaro
Measure:: 1          
Pay vs Performance Disclosure          
Name Normalized FFO/ Share        
Non-GAAP Measure Description Normalized FFO/Share is one of the primary measures used in our Annual Incentive Plan. Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. However, because real estate values historically have risen or fallen with market conditions, many industry investors deem presentations of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. For that reason, we consider Funds From Operations attributable to common stockholders (“FFO”) and Normalized FFO to be appropriate supplemental measures of operating performance of an equity REIT. For information regarding the calculation of Normalized FFO, please see Appendix A. To calculate Normalized FFO on per share basis, Normalized FFO is divided by weighted average diluted shares.        
Measure:: 2          
Pay vs Performance Disclosure          
Name Fixed Charge Coverage        
Measure:: 3          
Pay vs Performance Disclosure          
Name TSR Relative to the FTSE Nareit Equity Health Care Index        
Measure:: 4          
Pay vs Performance Disclosure          
Name TSR Relative to the MSCI U.S. REIT Index        
Measure:: 5          
Pay vs Performance Disclosure          
Name Net Debt to Further Adjusted EBITDA        
PEO          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ 23,013,401        
PEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
PEO | Aggregate Pension Adjustments Service Cost          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (12,015,051)        
PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 21,882,372        
PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 12,982,156        
PEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 1,711,613        
PEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (1,594,105)        
PEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 46,416        
PEO | Incremental Fair Value of Options and SARs [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
Non-PEO NEO          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 5,158,749        
Non-PEO NEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
Non-PEO NEO | Aggregate Pension Adjustments Service Cost          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (3,174,175)        
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 5,575,753        
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 2,774,037        
Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 0        
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 325,122        
Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount (358,076)        
Non-PEO NEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount 16,088        
Non-PEO NEO | Incremental Fair Value of Options and SARs [Member]          
Pay vs Performance Disclosure          
Adjustment to Compensation, Amount $ 0